Related Experiment Video

Updated: Aug 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Non-pharmacological therapy of hyperlipidaemia

Ugra Narayan Pathak1, Dipesh Lal Gurubacharya

  • 1Department of Medicine, Nepal Medical College Teaching Hospital, Attarkhel, Jorpati, Kathmandu, Nepal.

Nepal Medical College Journal : NMCJ
|March 18, 2004
PubMed

Insights

High blood cholesterol, or hyperlipidaemia, is a key factor in atherosclerosis and coronary heart disease (CHD). Lifestyle changes like diet and exercise are primary treatments, with medication used for high-risk individuals.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Public Health

Background:

  • Hyperlipidaemia is a significant societal issue, strongly linked to atherosclerosis and Coronary Heart Disease (CHD).
  • Elevated blood cholesterol levels are identified as a major modifiable risk factor for CHD development.
  • Low-density lipoprotein (LDL) cholesterol is specifically implicated as the primary lipoprotein driving atherosclerotic processes.

Purpose of the Study:

  • To review the role of hyperlipidaemia in cardiovascular disease.
  • To emphasize the importance of non-pharmacological interventions for managing elevated cholesterol.
  • To outline the criteria for initiating pharmacotherapy in hyperlipidaemia management.

Main Methods:

  • Review of clinical and epidemiological studies.
  • Analysis of risk factors for Coronary Heart Disease (CHD).
  • Evaluation of treatment strategies for hyperlipidaemia.

Main Results:

  • Hyperlipidaemia is a primary contributor to atherosclerosis and CHD.
  • Elevated LDL cholesterol is the main lipoprotein involved in atherosclerosis.
  • Non-pharmacological therapies (diet, exercise) are the first-line treatment for hyperlipidaemia.

Conclusions:

  • Dietary modifications and exercise are crucial first-line treatments for hyperlipidaemia.
  • Pharmacotherapy is reserved for high-risk CHD patients or those unresponsive to lifestyle interventions.
  • Managing hyperlipidaemia is essential for reducing the burden of atherosclerosis and CHD.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...